Skip to content

SCHEDULE 13G/AAccepted May 14, 10:30 AM ET

enGene Therapeutics Inc. SCHEDULE 13G/A

BML Investment Partners, L.P.

Accepted (ET)

10:30 AM

May 14, 2026

Filed

May 14, 2026

Documents

1

Size

6.6 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.